Models for Access to Maternal Smoking cessation Support (MAMSS): a study protocol of a quasi-experiment to increase the engagement of pregnant women who smoke in NHS Stop Smoking Services by unknown
Bennett et al. BMC Public Health 2014, 14:1041
http://www.biomedcentral.com/1471-2458/14/1041STUDY PROTOCOL Open AccessModels for Access to Maternal Smoking cessation
Support (MAMSS): a study protocol of a
quasi-experiment to increase the engagement
of pregnant women who smoke in NHS Stop
Smoking Services
Lorna Bennett1, Aimee Grant2*, Siobhan Jones3, Mererid Bowley4, Christian Heathcote-Elliott5, Catrin Ford5,
Angela Jones6, Rachel Lewis7, Margaret Munkley6, Carol Owen8, Annie Petherick4 and Shantini Paranjothy2,8Abstract
Background: Maternal smoking is a key cause of poor outcomes for mothers, babies and children and Wales has
higher rates of smoking in pregnancy than any other UK country. Despite various improvements within the NHS
Stop Smoking Service to strengthen the intervention for pregnant women, referrals and successful quit attempts for
this group have continued to remain extremely low. A key element of UK national guidance for smoking cessation
during pregnancy is to provide a flexible and tailored service to help increase levels of engagement. This study
aims to test the effectiveness of three different models of service delivery to address the gap in the evidence base
about how to deliver a flexible, tailored smoking cessation service to pregnant women.
Methods: This study will adopt a quasi-experimental design over a 12 month period. The setting is four of Wales’
seven Health Boards using an integrated approach between maternity services, local public health teams and the
NHS Stop Smoking Service. Core recommendations from UK public health guidance are being implemented across
intervention and usual care sites. Stop smoking support for pregnant women in intervention sites is being delivered
more flexibly than in usual care sites. Both qualitative and quantitative approaches will be adopted to capture
important contextual information and consider multiple perspectives. A health economic analysis will be undertaken
using a cost-consequences analysis approach. The primary outcome measure is engagement with stop smoking
services (defined as having at least one face-to-face therapeutic contact with a clinician).
Discussion: Supporting pregnant women to stop smoking is a challenging area of public health. The proposed
study will address several areas where there are key evidence gaps relating to smoking cessation interventions for
pregnant women. Specifically, how best to encourage pregnant women to attend a specialist stop smoking
support service, how to deliver the service and who should provide it.
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A third of pregnant women living in Wales smoke be-
fore or during their pregnancy compared to just over a
quarter of women living in other areas of the UK [1].
This is a major concern since maternal smoking is a key
cause of poor outcomes for mothers, babies and children.
It is associated with increased risk of miscarriage, perinatal
death, prematurity, low birth weight and congenital abnor-
malities in the baby in particular of the heart, face and
limbs [2,3]. Supporting pregnant women to stop smoking
is thus an important area of public health.
High quality evidence exists for interventions to pro-
mote smoking cessation in pregnancy. A Cochrane review
found that psychosocial interventions led to a reduction in
smoking during pregnancy and reduced the risk of low
birth weight and pre-term birth [4]. UK public health
guidance on interventions aimed at stopping smoking in
pregnancy and following childbirth provides a clear path-
way and referral mechanism for pregnant smokers into
NHS Stop Smoking Services [5].
A key component of this guidance is carbon monoxide
(CO) testing for all pregnant women to assess their level
of exposure to CO either as smokers themselves or from
other sources. Test results are used to ensure the appro-
priate identification of smokers for onward referral to
specialist support services. It has been estimated that 20
per cent of smokers deny their habit when cotinine mea-
surements are compared with self-report [6], leaving these
pregnant smokers without the information available to fa-
cilitate a quit attempt. It has been reported in UK based
research that employing the carbon monoxide test in con-
junction with self-report improves the identification of
smokers, but that maternity staff have found it difficult to
discuss smoking and administer the test [7].
A further key element of UK national guidance for
smoking cessation during pregnancy is to provide a flex-
ible and tailored service for pregnant women to help in-
crease levels of engagement. This is due to the fact that
pregnant women may not feel comfortable or have all
their needs met when attending generic services. Many
English stop smoking services offer a flexible service for
pregnant women [8]. However, it is not known how best
to deliver such a service or who should provide it.
Within the Welsh NHS Stop Smoking Servicea, various
service improvements have occurred since 2009 with a
view to strengthening the referral system for pregnant
women who smoke from antenatal units to the stop smok-
ing service. These service improvements have included
additional training of midwifery staff, in line with National
Institute for Health and Care Excellence (NICE) guidance,
to encourage the use of CO testing. Despite this, referrals
into the service and engagement with pregnant women
has continued to remain extremely low. For example, data
from the Stop Smoking Service show that in the referralperiod May 2012-March 2013, 1,817 pregnant smokers
were referred to the service from maternity services, but
only 529 went on to accept an appointment. At this time,
there were around 32,000 births in Wales [9] based on a
smoking prevalence of 33% [1], 5.6% of smokers were re-
ferred to the service, and 1.6% of smokers accepted an
appointment. In response, key partners were brought to-
gether across Wales to develop a public health study,
Models for Access to Maternal Smoking cessation Support
(MAMSS) with the aim of testing the effectiveness of
three different models of service delivery to address the
gap in the evidence base about how to deliver a flexible
tailored smoking cessation service to pregnant women.
Methods
This study will be undertaken as a quasi-experimental
design. Donabedian’s conceptual model for examining
health services and evaluating quality of care as a frame-
work for examining structures, processes and outcomes
will be applied [10]. The setting will be four of Wales’
seven Health Boards. These are single local health organi-
sations responsible for planning, securing and delivering
all healthcare services within a geographical area. The
Health Boards involved in the study are self-selected and
are geographically diverse. Total population figures range
from 294,497 to 690,434 [11] and live births range from
63.9 to 66.3 per 1000 women aged 15-44 [9] (see Table 1).
Interventions
The study will take place over 12 months using an inte-
grated approach between maternity services, local public
health teams and the NHS Stop Smoking Service. In
each Health Board, an intervention and a usual care site
will be selected from existing community midwifery teams.
Sites will be selected on the basis of high rates of pregnant
smokers, and a similar demographic profile in intervention
and usual care sites within each Health Board. Pregnant
smokers (i.e. those who are self-reported current smokers
or have a CO reading # 7 ppmb,c or who have quit in the
two weeks prior to their booking appointment [5]) will be
referred to the intervention or usual care NHS Stop Smok-
ing Service on an opt out basis (see Figures 1 and 2). This
automatically refers pregnant smokers to the service. The
two main points for referral are the first antenatal appoint-
ment (at home or in a community antenatal clinic by the
midwife) or subsequent scheduled antenatal care visits (by
the midwife). However, the referral process can take place
at any stage during pregnancy, for example, during the
postpartum period whilst under the care of a midwife.
In intervention sites, pregnant smokers will be referred
to one of three different models of service delivery where
smoking cessation services are provided by maternity sup-
port workers, midwives or smoking cessation advisors
dedicated to working with pregnant women, all offering a
Table 1 Total population and live births per 1000 for
Health Boards participating in MAMSS
Health board Total population [11] Live births per 1000
women aged 15-44 [9]
Health board 1 519,781 60.0
Health board 2 577,981 61.8
Health board 3 690,704 64.8
Health board 4 294,497 61.7
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The core elements of the evidence base to be imple-
mented in all intervention sites will include:
 Strict adherence to NICE opt out smoking cessation
pathway for pregnant women, including CO
monitoring.
 Smoking cessation services being more closely
aligned to maternity services (provided as part of the
package of maternity care).
 Referral from midwife to smoking cessation support
within 48 hours
 Flexibility in service model with a women centred
approach.
Each intervention site will recruit a whole-time equiva-
lent (WTE) maternity support worker (employed by the
Health Board), midwife (employed by the Health Board)
or dedicated Stop Smoking Advisor for pregnant women
(employed by the NHS Stop Smoking Service) who will
deliver stop smoking support to pregnant women. These
staff will receive referrals directly from midwives to pro-
vide an intensive smoking cessation intervention at times
and settings of the women’s choice, including home visits.
During every subsequent antenatal appointment, women
will be asked about their smoking status and referred as
appropriate. If a woman has declined treatment (i.e. she
opts-out by not answering the telephone to stop smoking
services or refuses an assessment appointment) she will be
asked if she would like to be re-referred during each
follow-up appointment.
Clients in intervention sites will be offered smoking ces-
sation support for the duration of their pregnancy if re-
quired. The support they receive will follow an adapted
behavioural intervention model documented in the NHS
Stop Smoking Service delivery manual, which is based on
withdrawal oriented therapy (Maudsley model) [12]. This
may involve a combination of telephone and face to face
support as well as motivational support by email and or
text, dependent upon the needs of the client (see Figure 1).
A detailed manual for specialist smoking cessation staff
has been developed for use in all intervention sites detail-
ing the referral pathway, intervention programme, policies,
procedures and support materials.Comparison group (usual care)
Pregnant smokers will be referred on an opt out basis to
NHS Stop Smoking Services in usual care sites. The core
elements of this service are:
 Referrals received by NHS Stop Smoking Service
from midwives via fax or phone call.
 Stop smoking staff make an attempt to contact the
pregnant women within 48 hours to discuss benefits
of quitting, offer support and arrange an assessment
session.
 NHS Stop Smoking Service staff attempt to contact
the client by telephone twice more if contact has
not been established, and send a follow up letter if
no response.
 Clients who do not opt out are fast tracked into a
one-to-one assessment session appointment within
48 hours. Assessment sessions are conducted in
community venues.
 Women are offered six further sessions of intensive
behavioural support in community venues or by
telephone.
 If the client requires additional support following
the seven sessions, the advisor will arrange to make
contact by telephone in two weeks to provide an
additional follow up.
Outcome measures
The primary outcome measure is engagement with stop
smoking services (defined as having at least one face-to-
face therapeutic contact with an advisor) and secondary
outcome measures are pregnant smokers who set a quit
date; pregnant smokers who quit at four weeks follow-
up (CO verified); smoking status at the time of birth or
third trimester and 52 weeks; and birth outcomes (low
birth weight (<2500 g), preterm birth <37 weeks).
Process measures will assess fidelity to protocols, feasi-
bility, acceptability, maintenance and sustainability should
the interventions be rolled out on a wider scale. Data will
be obtained from available data sources within maternity
services and the NHS Stop Smoking Service on specific
aspects of the referral pathway and treatment programme.
Sample
Women who are pregnant and smoke or who have quit
smoking in the two weeks prior to their initial antenatal
booking appointment will be eligible to participate. The
inclusion criteria are pregnant or postnatal women,
under the care of a midwife, who are either a current
smoker (self-report or verified through CO reading of ≥
7 ppm2) or ex-smoker (quit within two weeks prior to
booking appointment). The exclusion criteria are preg-
nant women who are not smokers or who have reduced
mental capacity.
Figure 1 Referral and treatment in usual care and intervention sites.
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Figure 2 Recruitment flow diagram.
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We hypothesise that the flexible models of service deliv-
ery can increase the percentage of pregnant women who
engage with smoking cessation services from 10 per cent
(current rate of engagement in NHS England smoking
cessation services) to 25 per cent. A sample size of 146
pregnant smokers in each group within each Health
Board will allow a 15 per cent difference to be detected
in the proportion of pregnant smokers who engage, with
a five per cent type I error rate and 90 per cent power.
Quantitative data collection
Quantitative data collection will principally utilise rou-
tine data from: i) the Health Board’s electronic Patient
Administration System (PAS) and Maternity Information
System, which contain information about expectant
mothers smoking status and birth outcomes and ii) the
NHS Stop Smoking Service database which will record
referral and treatment information for all intervention
and usual care clients. Each Health Board uses a national
standardised maternity record. The maternity record
aims to improve quality and safety of maternity care and
is updated regularly according to national guidelines to
represent the latest recommendations for best practice.Within the record, there is a comprehensive risk assess-
ment which identifies individual risk factors, including
smoking status, for the expectant mother. Data from the
patient hand-held record is entered into each Health
Board’s electronic PAS and Maternity Information System
(where available). Additional file 1 provides detail about
the specific data items to be extracted from the PAS and
Maternity Information System for this study.
Information about the referral pathway and stop smok-
ing treatment programme will be entered onto a separate
database used by the existing NHS Stop Smoking Service
which has recently undergone developments including the
ability to conduct e-referrals. Data items to be extracted
are detailed in Additional file 1. To facilitate this process,
Memoranda of Understanding (MoU) will be established
between Public Health Wales Informatics team and the
four participating Health Boards and between Public
Health Wales Informatics and the NHS Stop Smoking
Service which will allow Public Health Wales to hold and
process Health Board and NHS Stop Smoking Service data
on their behalf. Approval will be sought from each Health
Board and the NHS Stop Smoking Service to allow Public
Health Wales Informatics to release anonymised data to
specified analysts for use in accordance with an agreed
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will act as the NHS Stop Smoking Service’s and the Health
Board’s agent in this process and undertake any linking
that has to be undertaken before anonymising the data
and providing it to analysts. All data will be anonymised,
therefore patient confidentiality will be maintained. All
documents will be stored securely and only accessible by
study staff and authorised personnel. The study will com-
ply with the Data Protection Act which requires data to be
anonymised as soon as it is practical to do so.
Analysis
Baseline demographic and social characteristics of preg-
nant smokers in both intervention and usual care sites
will be summarised using descriptive statistics. Compari-
sons between the two groups will be carried out using a
Student’s t-test or a non-parametric test for continuous
data and a chi-squared test or a Fisher’s exact test for
categorical data. Characteristics of women who do not
opt out of the referral will be compared to those who
do. Continuous data will be expressed as mean values
with standard deviations and categorical data will be
presented as counts with percentages. A single logistic
regression model will be developed to obtain odds ratios
for the comparison of different interventions with usual
care, and for comparisons between interventions. Differ-
ences in baseline characteristics of individuals and refer-
ral rates for Stop Smoking Services will be adjusted for.
To account for the geographical clustering of individ-
uals, robust standard errors will be calculated.
Qualitative evaluation
Staff delivering treatment or referring women for treat-
ment in all usual care areas and in three of the interven-
tion areas will be invited to take part in semi-structured
interviews. All 32 usual care advisors will be emailed
with an information sheet and asked to contact the re-
searcher if they are experienced in supporting pregnant
women. If low response occurs, further invitations will
be sent by email. Staff in selected intervention areas will
be recruited via the Health Board’s lead or co-lead for
the study. Staff will have the opportunity to undertake
an interview either face-to-face within a private room in
their work place, or by telephone at a time that is con-
venient for them.
Clients who receive treatment will be invited to take part
in the study by the staff delivering their treatment. If a cli-
ent expresses an interest in the study, staff will provide
them with an information sheet, containing contact details
for the researcher. The client can then opt in by contact-
ing the researcher. Whilst staff introduction will introduce
bias into the sample, and a low response rate is likely due
to the opt-in procedure, it will allow vulnerable women
the opportunity to take part in research. In order tominimise data collection costs in a large research site, en-
sure researcher safety and to encourage clients to be open
about their treatment, interviews will be conducted by tele-
phone. Whilst traditionally face-to-face interviewing has
been seen as important for health research, the advantages
of telephone interviewing are increasingly recognised [13].
If participants consent, interviews will be audio re-
corded and transcribed verbatim. Comprehensive notes
will be taken if consent is refused. Qualitative data will
be analysed using a structured approach, Framework
analysis, which involves five stages: familiarisation, con-
structing an initial framework, coding, reviewing data
extracts and conclusion drawing [14]. Transcripts will be
coded by hand, before being displayed in tables, with all
instances of one code examined together. Finally conclu-
sions will be drawn by identifying salient themes in the
tables. The use of a structured approach aims to minim-
ise researcher bias. Moreover, each stage of the analysis
will be agreed by two researchers, with inconsistencies
discussed and resolved.
Economic evaluation
A health economic analysis will be undertaken using a
cost-consequences analysis approach. Over a period of
12-months, cost data will be collected on wages, travel,
training, NRT prescribing and average length of inter-
vention per client. Summary information for these costs
will be presented in a tabular format against the conse-
quences of each intervention. Consequences are defined
as the primary and secondary outcome measures previ-
ously described.
Ethical considerations
We contacted the Research and Development manager
for all four sites. One Health Board, Cwm Taf Health
Board, received NHS ethical approval (South East Wales
Research Ethics Committee). In the other three sites the
research was declared service evaluation by the Research
and Development manager (Abertawe Bro Morgannwg
University Health Board ), the Clinical Audit and Effect-
iveness Manager (Betsi Cadwaladar University Health
Board) and the Aneurin Bevan Health Board Research
Risk Review Committee (Aneurin Bevan Health Board).
As a result the project did not require NHS ethical ap-
proval. This decision was approved by the NHS Research
Ethics Committee (REC) for Wales. Research and devel-
opment approvals were obtained from all four Health
Boards and Public Health Wales NHS Trust.
Discussion
A quasi-experimental design for the proposed study was
adopted as it was not logistically feasible to conduct a
cluster randomised controlled trial in the desired time-
scales and within the available budget [15]. Although the
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have the highest level of credibility with regard to asses-
sing causality, the use of a comparison group helps pre-
vent certain threats to validity including the ability to
statistically adjust for confounding variables.
The proposed study will address several areas where
there are key evidence gaps relating to pregnant women
and smoking cessation interventions. Specifically, how
best to encourage pregnant women to attend a specialist
stop smoking support service, how to deliver the service
and who should provide it. The study will reveal important
findings in relation to service delivery and enable local ser-
vices to improve their effectiveness in a challenging area
of public health. Ensuring better identification of pregnant
smokers and providing access to timely support from
smoking cessation specialists is crucial to reducing the
number of women smoking during pregnancy in Wales.
Investigating ways to provide a more flexible, women-
centred approach is an important development which will
assist in reducing the range of adverse factors for both
mother and baby associated with maternal smoking
behaviour.
Endnotes
aThe NHS Stop Smoking Service in Wales is known as
Stop Smoking Wales. The service is funded and run by
Public Health Wales NHS Trust - an NHS organisation
providing professionally independent public health ad-
vice and services to protect and improve the health and
wellbeing of the population of Wales. It contributes to
national and local tobacco control initiatives and has a
key role in reducing the impact of tobacco on the health
of people in Wales.
bA lower level (e.g. 3 ppm) may apply for light/infre-
quent smokers. A higher level might apply if prior expos-
ure to other sources of pollution e.g. traffic fume, leaky
gas appliances [5].
cThe use of 7 ppm2 was adopted as it was accepted best
practice, contained in NICE guidance, at the time of the
research design. It is likely that NICE will move to 4 ppm2
in the future, and some existing research is already using
this definition. We recommend that future research use a
definition of 4 ppm2.Additional file
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